| AAV vector integration sites in mouse hepatocellular carcinoma A Donsante, DG Miller, Y Li, C Vogler, EM Brunt, DW Russell, MS Sands Science 317 (5837), 477-477, 2007 | 760 | 2007 |
| Gene therapy for lysosomal storage diseases MS Sands, BL Davidson Molecular Therapy 13 (5), 839-849, 2006 | 357 | 2006 |
| Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors A Donsante, C Vogler, N Muzyczka, JM Crawford, J Barker, T Flotte, ... Gene therapy 8 (17), 1343-1346, 2001 | 355 | 2001 |
| Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells MA Young, DE Larson, CW Sun, DR George, L Ding, CA Miller, L Lin, ... Cell stem cell 10 (5), 570-582, 2012 | 258 | 2012 |
| Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transfer JH Wolfe, MS Sands, JE Barker, B Gwynn, LB Rowe, CA Vogler, ... Nature 360 (6406), 749-753, 1992 | 247 | 1992 |
| In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation models TE Meyerrose, DA De Ugarte, AA Hofling, PE Herrbrich, TD Cordonnier, ... Stem cells 25 (1), 220-227, 2007 | 244 | 2007 |
| Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease TM Daly, C Vogler, B Levy, ME Haskins, MS Sands Proceedings of the National Academy of Sciences 96 (5), 2296-2300, 1999 | 237 | 1999 |
| Recombinant adeno-associated viral integration and genotoxicity: insights from animal models RJ Chandler, MS Sands, CP Venditti Human gene therapy 28 (4), 314-322, 2017 | 234 | 2017 |
| Enzyme replacement therapy for murine mucopolysaccharidosis type VII. MS Sands, C Vogler, JW Kyle, JH Grubb, B Levy, N Galvin, WS Sly, ... The Journal of clinical investigation 93 (6), 2324-2331, 1994 | 230 | 1994 |
| CMV-β-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1α promoter and results in … L Xu, T Daly, C Gao, TR Flotte, S Song, BJ Byrne, MS Sands, KP Ponder Human gene therapy 12 (5), 563-573, 2001 | 219 | 2001 |
| Marrow stromal cells and osteoclast precursors differentially contribute to TNF-α-induced osteoclastogenesis in vivo H Kitaura, MS Sands, K Aya, P Zhou, T Hirayama, B Uthgenannt, S Wei, ... The Journal of Immunology 173 (8), 4838-4846, 2004 | 218 | 2004 |
| Clinical course of sly syndrome (mucopolysaccharidosis type VII) AM Montaño, N Lock-Hock, RD Steiner, BH Graham, M Szlago, ... Journal of medical genetics 53 (6), 403-418, 2016 | 195 | 2016 |
| Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis C Kielar, L Maddox, E Bible, CC Pontikis, SL Macauley, MA Griffey, ... Neurobiology of disease 25 (1), 150-162, 2007 | 191 | 2007 |
| Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates. MS Sands, JE Barker, C Vogler, B Levy, B Gwynn, N Galvin, WS Sly, ... Laboratory investigation; a journal of technical methods and pathology 68 (6 …, 1993 | 185 | 1993 |
| Central amygdala glucocorticoid receptor action promotes fear-associated CRH activation and conditioning BJ Kolber, MS Roberts, MP Howell, DF Wozniak, MS Sands, LJ Muglia Proceedings of the National Academy of Sciences 105 (33), 12004-12009, 2008 | 182 | 2008 |
| Niemann-Pick C1 protects against atherosclerosis in mice via regulation of macrophage intracellular cholesterol trafficking JR Zhang, T Coleman, SJ Langmade, DE Scherrer, L Lane, MH Lanier, ... The Journal of clinical investigation 118 (6), 2281-2290, 2008 | 165 | 2008 |
| CNS-directed AAV2-mediated gene therapy ameliorates functional deficits in a murine model of infantile neuronal ceroid lipofuscinosis MA Griffey, D Wozniak, M Wong, E Bible, K Johnson, SM Rothman, ... Molecular Therapy 13 (3), 538-547, 2006 | 161 | 2006 |
| VEGF increases engraftment of bone marrow-derived endothelial progenitor cells (EPCs) into vasculature of newborn murine recipients PP Young, AA Hofling, MS Sands Proceedings of the National Academy of Sciences 99 (18), 11951-11956, 2002 | 158 | 2002 |
| Prevention of systemic clinical disease in MPS VII mice following AAV-mediated neonatal gene transfer TM Daly, KK Ohlemiller, MS Roberts, CA Vogler, MS Sands Gene therapy 8 (17), 1291-1298, 2001 | 148 | 2001 |
| AAV-mediated liver-directed gene therapy MS Sands Adeno-Associated Virus: Methods and Protocols, 141-157, 2011 | 147 | 2011 |